Skip to main content
. Author manuscript; available in PMC: 2010 Apr 29.
Published in final edited form as: Int J Cancer. 2009 Aug 1;125(3):680–687. doi: 10.1002/ijc.24369

Table 3.

Case-Control Odds Ratios for IgE Levels, San Francisco Bay Area Adult Glioma Study (2001–2005)

Controls
All cases
n mean ± SE n mean ± SE OR* (95% CI) p-value
Ln (Total IgE)** 470 3.49 ± 0.69 393 3.26 ± 0.079 0.89 (0.82–0.98) 0.01

n % n % OR* (95% CI) p-value

Total IgE
 Normal, <25 199 42 197 50 1.00
 Boderline, 25 to 100 165 35 111 28 0.66 (0.48–0.90) 0.05
 Elevated, >100 106 23 85 22 0.79 (0.55–1.12) 0.18

Respiratory IgE
 Nonelevated 273 58 244 62 1.00
 Elevated 197 42 148 38 0.80 (0.60–1.06) 0.12

Food IgE
 Nonelevated 431 92 372 95 1.00
 Elevated 39 8 19 5 0.58 (0.33–1.03) 0.06

IgE Quartiles
 Quartile 1 117 25 123 31 1.00 0.07***
 Quartile 2 118 25 90 23 0.69 (0.47–1.01) 0.05
 Quartile 3 118 25 89 23 0.68 (0.47–1.00) 0.05
 Quartile 4 117 25 91 23 0.70 (0.48–1.03) 0.07
*

Models were adjusted for age, gender, ethnicity, college education and smoking history

**

Ln(IgE) was expressed as a continuous variable.

***

P-value for overall trend test.

HHS Vulnerability Disclosure